These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
225 related articles for article (PubMed ID: 34838594)
1. Surveillance and control of meningococcal disease in the COVID-19 era: A Global Meningococcal Initiative review. Alderson MR; Arkwright PD; Bai X; Black S; Borrow R; Caugant DA; Dinleyici EC; Harrison LH; Lucidarme J; McNamara LA; Meiring S; Sáfadi MAP; Shao Z; Stephens DS; Taha MK; Vazquez J; Zhu B; Collaborators G J Infect; 2022 Mar; 84(3):289-296. PubMed ID: 34838594 [TBL] [Abstract][Full Text] [Related]
2. Meningococcal disease surveillance in the Asia-Pacific region (2020): The global meningococcal initiative. Aye AMM; Bai X; Borrow R; Bory S; Carlos J; Caugant DA; Chiou CS; Dai VTT; Dinleyici EC; Ghimire P; Handryastuti S; Heo JY; Jennison A; Kamiya H; Tonnii Sia L; Lucidarme J; Marshall H; Putri ND; Saha S; Shao Z; Sim JHC; Smith V; Taha MK; Van Thanh P; Thisyakorn U; Tshering K; Vázquez J; Veeraraghavan B; Yezli S; Zhu B J Infect; 2020 Nov; 81(5):698-711. PubMed ID: 32730999 [TBL] [Abstract][Full Text] [Related]
3. Acquisition of Ciprofloxacin Resistance Among an Expanding Clade of β-Lactamase-Positive, Serogroup Y Neisseria meningitidis in the United States. Potts CC; Retchless AC; McNamara LA; Marasini D; Reese N; Swint S; Hu F; Sharma S; Blain AE; Lonsway D; Karlsson M; Hariri S; Fox LM; Wang X; Clin Infect Dis; 2021 Oct; 73(7):1185-1193. PubMed ID: 33900407 [TBL] [Abstract][Full Text] [Related]
4. Molecular characterization of a collection of Neisseria meningitidis isolates from Croatia, June 2009 to January 2014. Bukovski S; Vacca P; Anselmo A; Knezovic I; Fazio C; Neri A; Ciammaruconi A; Fortunato A; Palozzi AM; Fillo S; Lista F; Stefanelli P J Med Microbiol; 2016 Sep; 65(9):1013-1019. PubMed ID: 27452726 [TBL] [Abstract][Full Text] [Related]
5. Prevention and control of meningococcal disease: Updates from the Global Meningococcal Initiative in Eastern Europe. Bai X; Borrow R; Bukovski S; Caugant DA; Culic D; Delic S; Dinleyici EC; Eloshvili M; Erdősi T; Galajeva J; Křížová P; Lucidarme J; Mironov K; Nurmatov Z; Pana M; Rahimov E; Savrasova L; Skoczyńska A; Smith V; Taha MK; Titov L; Vázquez J; Yeraliyeva L J Infect; 2019 Dec; 79(6):528-541. PubMed ID: 31682877 [TBL] [Abstract][Full Text] [Related]
6. Reactive vaccination as control strategy for an outbreak of invasive meningococcal disease caused by Fazio C; Daprai L; Neri A; Tirani M; Vacca P; Arghittu M; Ambrosio L; Cereda D; Gramegna M; Palmieri A; Carannante A; Bertoli MR; Crottogini L; Gennati G; Quinz E; Trezzi L; Ciammaruconi A; Fillo S; Fortunato A; Rezza G; Lista F; Stefanelli P Euro Surveill; 2022 Jun; 27(24):. PubMed ID: 35713021 [TBL] [Abstract][Full Text] [Related]
7. Global estimate of Neisseria meningitidis serogroups proportion in invasive meningococcal disease: A systematic review and meta-analysis. Purmohamad A; Abasi E; Azimi T; Hosseini S; Safari H; Nasiri MJ; Imani Fooladi AA Microb Pathog; 2019 Sep; 134():103571. PubMed ID: 31163252 [TBL] [Abstract][Full Text] [Related]
8. Meningococcal disease in the Middle East: A report from the Global Meningococcal Initiative. Al-Abri SS; Abuhasan MY; Albayat SSA; Bai X; Bastaki H; Borrow R; Caugant DA; Dbaibo G; Deghmane AE; Dinleyici EC; Ghuneim N; Sheek-Hussein M; Lucidarme J; Leng S; Koliou MG; Sáfadi MAP; Salman JA; Al-Sanouri T; Smith V; Taha MK; Vázquez J; Wright C; Yezli S J Infect; 2024 Feb; 88(2):71-76. PubMed ID: 37866792 [TBL] [Abstract][Full Text] [Related]
9. Population structure and capsular switching of invasive Neisseria meningitidis isolates in the pre-meningococcal conjugate vaccine era--United States, 2000-2005. Harrison LH; Shutt KA; Schmink SE; Marsh JW; Harcourt BH; Wang X; Whitney AM; Stephens DS; Cohn AA; Messonnier NE; Mayer LW J Infect Dis; 2010 Apr; 201(8):1208-24. PubMed ID: 20199241 [TBL] [Abstract][Full Text] [Related]
10. [Invasive meningococcal disease in the Czech Republic - analysis of the epidemiological situation and vaccination strategy recommendations]. Křížová P; Vacková Z; Musílek M; Kozáková J Epidemiol Mikrobiol Imunol; 2013 Dec; 62(4):138-47. PubMed ID: 24467175 [TBL] [Abstract][Full Text] [Related]
11. Invasive meningococcal disease epidemiology and characterization of Neisseria meningitidis serogroups, sequence types, and clones; implication for use of meningococcal vaccines. Stein-Zamir C; Shoob H; Abramson N; Block C; Keller N; Jaffe J; Valinsky L Hum Vaccin Immunother; 2019; 15(1):242-248. PubMed ID: 30156954 [TBL] [Abstract][Full Text] [Related]
12. Meningococcal disease in North America: Updates from the Global Meningococcal Initiative. Asturias EJ; Bai X; Bettinger JA; Borrow R; Castillo DN; Caugant DA; Chacon GC; Dinleyici EC; Echaniz-Aviles G; Garcia L; Glennie L; Harrison LH; Howie RL; Itsko M; Lucidarme J; Marin JEO; Marjuki H; McNamara LA; Mustapha MM; Robinson JL; Romeu B; Sadarangani M; Sáez-Llorens X; Sáfadi MAP; Stephens DS; Stuart JM; Taha MK; Tsang RSW; Vazquez J; De Wals P J Infect; 2022 Dec; 85(6):611-622. PubMed ID: 36273639 [TBL] [Abstract][Full Text] [Related]
13. A Review of the Epidemiology of Invasive Meningococcal Disease and Vaccination Strategies in North Africa. Taha MK; Presa J; Serra L Int J Infect Dis; 2021 Mar; 104():189-197. PubMed ID: 33227521 [TBL] [Abstract][Full Text] [Related]
14. Genomic characterization of invasive meningococcal X isolates from Brazil, 1992-2022. Cassiolato AP; Camargo CH; Piccoli Cecconi MC; Christakis S; Gonçalves CR; Rodrigues Campos K; Takenori Higa F; Andrade Pereira G; de Moraes C; Silva de Lemos AP Int Microbiol; 2023 Aug; 26(3):611-618. PubMed ID: 36626096 [TBL] [Abstract][Full Text] [Related]
15. Vaccination strategies for the prevention of meningococcal disease. Vuocolo S; Balmer P; Gruber WC; Jansen KU; Anderson AS; Perez JL; York LJ Hum Vaccin Immunother; 2018 May; 14(5):1203-1215. PubMed ID: 29543535 [TBL] [Abstract][Full Text] [Related]
16. Meningococcal serogroups and surveillance: a systematic review and survey. Peterson ME; Li Y; Bita A; Moureau A; Nair H; Kyaw MH; ; Abad R; Bailey F; Garcia IF; Decheva A; Krizova P; Melillo T; Skoczynska A; Vladimirova N J Glob Health; 2019 Jun; 9(1):010409. PubMed ID: 30603079 [TBL] [Abstract][Full Text] [Related]
17. The Global Meningococcal Initiative meeting on prevention of meningococcal disease worldwide: Epidemiology, surveillance, hypervirulent strains, antibiotic resistance and high-risk populations. Acevedo R; Bai X; Borrow R; Caugant DA; Carlos J; Ceyhan M; Christensen H; Climent Y; De Wals P; Dinleyici EC; Echaniz-Aviles G; Hakawi A; Kamiya H; Karachaliou A; Lucidarme J; Meiring S; Mironov K; Sáfadi MAP; Shao Z; Smith V; Steffen R; Stenmark B; Taha MK; Trotter C; Vázquez JA; Zhu B Expert Rev Vaccines; 2019 Jan; 18(1):15-30. PubMed ID: 30526162 [TBL] [Abstract][Full Text] [Related]
18. [Clonal analysis of the meningococcal populations from invasive disease and healthy carriers isolated in the Czech Republic in 1971-2014 (May)]. Jandová Z; Musílek M; Vacková Z; Kozáková J; Křížová P Epidemiol Mikrobiol Imunol; 2015 Sep; 64(3):147-52. PubMed ID: 26448302 [TBL] [Abstract][Full Text] [Related]
19. Invasive Meningococcal Disease, 2011-2020, and Impact of the COVID-19 Pandemic, England. Subbarao S; Campbell H; Ribeiro S; Clark SA; Lucidarme J; Ramsay M; Borrow R; Ladhani S Emerg Infect Dis; 2021 Sep; 27(9):2495-2497. PubMed ID: 34193335 [TBL] [Abstract][Full Text] [Related]
20. Epidemiology of serogroup C and Y invasive meningococcal disease (IMD) in Ontario, 2000-2013: Vaccine program impact assessment. Wormsbecker AE; Wong K; Jamieson FB; Crowcroft NS; Deeks SL Vaccine; 2015 Oct; 33(42):5678-5683. PubMed ID: 26299749 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]